UNSPSC 41131701: Adenosine triphosphate release assay

In this classification an adenosine triphosphate release assay is a device that measures the release of adenosine triphosphate (ATP) from platelets following aggregation. This measurement is made on platelet-rich plasma using a photometer and a luminescent firefly extract. Simultaneous measurements of platelet aggregation and ATP release are used to evaluate platelet function disorders US FDA regulates Adenosine triphosphate release assay under 21 CFR 864.7040 and under FDA product code KHF.

UNSPSC 41131701 Adenosine triphosphate release assay is a Commodity code that encompasses laboratory drug-screening and testing consumables, supplies, and associated analytical services purchased by state and local jurisdictions—including community supervision departments, county health services, forensic laboratories, and municipal occupational health programs. Recent solicitations show demand concentrated on immunoassay screening supplies, confirmatory testing reagents and equipment, drug panel consumables, urinalysis test kits, and proprietary assay systems for controlled-substance detection across forensic, occupational health, and public safety applications. The code covers both the direct purchase of testing supplies (collection kits, reference standards, analyzer consumables) and broader testing services involving specimen collection, result reporting, and electronic data management. Issuing bodies include county criminal-justice and community supervision departments (Collin County, Texas; Seminole County, Florida; Benton County, Oregon), county health services (Collin County Health Care Services; Bernalillo County), state forensic and laboratory divisions (Texas Department of Public Safety through the Texas Comptroller; Oregon Health Authority), Georgia county government (Gwinnett County), and municipal agencies (City of Charlotte). State procurement offices and university medical systems also solicit under this code.

The most recent activity concentrates in Texas, Georgia, Florida, and Oregon. Collin County Community Supervision and Corrections Department released RFP 2026-327 on September 25, 2026 for offender specimen collection and drug testing services with an estimated contract value of $600,000, covering two collection sites, immunoassay and LC/MS/MS or GC/MS confirmation testing, and approximately 25,031 annual tests across five- and six-panel drug screens; proposals were due July 23, 2026. The Texas Comptroller of Public Accounts Statewide Procurement Division issued IFB 304T-27-175A1.1 on September 23, 2026 for proprietary chemical laboratory equipment and supplies serving the Texas Department of Public Safety, with bid responses due October 20, 2026, covering specialized DNA and drug-screening reagents, genetic analyzer components, and Direct ELISA kits for detecting cannabinoids, opiates, amphetamines, cocaine, benzodiazepines, and other controlled substances from vendors including Life Technologies, Promega, Qiagen, and Immunalysis Corporation. Benton County, Oregon solicited urinalysis testing services for its Family Treatment Court Program through an RFP with a July 6, 2026 response deadline, requiring CLIA-certified laboratory services with twice-weekly testing, standard drug panels, and confirmatory testing for all positives. Pinellas County, Florida issued Invitation to Quote 26-0305-ITQ for certified drug reference standards (131 line items) for forensic laboratory validation and evidentiary analysis, with responses due April 23, 2026 and $49,034 in federal funding available through the Paul Coverdell Forensic Sciences Improvement Act Program.